Geneos Wealth Management’s Avantis US Small Cap Value ETF AVUV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$780K Sell
6,248
-4
-0.1% -$477 0.02% 602
2026
Q1
$691K Buy
6,252
+511
+9% +$56.3K 0.02% 601
2025
Q4
$585K Hold
5,741
0.01% 624
2025
Q3
$571K Sell
5,741
-202
-3% -$19.5K 0.01% 616
2025
Q2
$541K Buy
5,943
+3,077
+107% +$265K 0.01% 684
2025
Q1
$250K Buy
2,866
+302
+12% +$28.4K 0.01% 829
2024
Q4
$248K Buy
2,564
+642
+33% +$63.8K 0.01% 772
2024
Q3
$184K Buy
1,922
+324
+20% +$30.3K 0.01% 794
2024
Q2
$143K Sell
1,598
-965
-38% -$87.4K 0.01% 783
2024
Q1
$240K Buy
2,563
+2,273
+784% +$201K 0.01% 655
2023
Q4
$26K Hold
290
﹤0.01% 1269
2023
Q3
$22.6K Hold
290
﹤0.01% 1338
2023
Q2
$22.5K Buy
290
+140
+93% +$10.3K ﹤0.01% 1332
2023
Q1
$11.1K Hold
150
﹤0.01% 1522
2022
Q4
$11.2K Hold
150
﹤0.01% 1500
2022
Q3
$9K Buy
+150
New +$10.9K ﹤0.01% 1532

Other funds holding AVUV

Geneos Wealth Management's AVUV Position: Q2 2026 in Review

Geneos Wealth Management reduced its Avantis US Small Cap Value ETF (AVUV) stake by 0.06% in Q2 2026, selling an estimated $477 and leaving 6,248 shares worth $780K. The position accounts for 0.02% of the portfolio, ranked #602.

Geneos Wealth Management first reported a position in AVUV in Q3 2022 and has held it in 16 quarters since. 1,139 funds tracked by Wall St. Rank hold AVUV as of Q2 2026.

  • Geneos Wealth Management held 6,248 shares of Avantis US Small Cap Value ETF worth $780K as of Q2 2026.
  • Geneos Wealth Management sold 4 Avantis US Small Cap Value ETF shares in Q2 2026, an estimated $477.
  • Avantis US Small Cap Value ETF made up 0.02% of Geneos Wealth Management's portfolio in Q2 2026, its #602 holding.
  • Geneos Wealth Management first reported a position in Avantis US Small Cap Value ETF in Q3 2022 and has held it in 16 quarters since.
  • 1,139 funds tracked by Wall St. Rank held Avantis US Small Cap Value ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.